HAEMONETICS CORP - Common Stock (HAE)

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / Common Stock
Shares outstanding
47,898,935
Total 13F shares
52,124,856
Share change
-987,403
Total reported value
$1,684,666,056
Price per share
$32.32
Number of holders
168
Value change
-$42,369,690
Number of buys
93
Number of sells
84

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q3 2015

As of 30 Sep 2015 HAEMONETICS CORP - Common Stock (HAE) had 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 52,124,856 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Neuberger Berman Group LLC, BlackRock Fund Advisors, WELLS FARGO & COMPANY/MN, BARROW HANLEY MEWHINNEY & STRAUSS LLC, Black Creek Investment Management Inc., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, WESTWOOD HOLDINGS GROUP INC, and WELLINGTON MANAGEMENT GROUP LLP.
This table shows 168 institutional shareholders of the security as of 30 Sep 2015.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.